rdf:type |
|
lifeskim:mentions |
|
pubmed:issue |
3
|
pubmed:dateCreated |
2010-2-26
|
pubmed:abstractText |
Dual blockade of the renin-angiotensin system (RAS) has been claimed to have a specific renal protective effect in chronic kidney disease (CKD). The present short-term study reports on the feasibility of dual blockade in a consecutive group of patients with CKD stage 3-5.
|
pubmed:language |
eng
|
pubmed:journal |
|
pubmed:citationSubset |
IM
|
pubmed:chemical |
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
1460-2385
|
pubmed:author |
|
pubmed:issnType |
Electronic
|
pubmed:volume |
25
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
842-7
|
pubmed:meshHeading |
pubmed-meshheading:19903661-Aged,
pubmed-meshheading:19903661-Angiotensin II Type 1 Receptor Blockers,
pubmed-meshheading:19903661-Angiotensin-Converting Enzyme Inhibitors,
pubmed-meshheading:19903661-Benzimidazoles,
pubmed-meshheading:19903661-Blood Pressure,
pubmed-meshheading:19903661-Chronic Disease,
pubmed-meshheading:19903661-Disease Progression,
pubmed-meshheading:19903661-Dose-Response Relationship, Drug,
pubmed-meshheading:19903661-Drug Therapy, Combination,
pubmed-meshheading:19903661-Enalapril,
pubmed-meshheading:19903661-Feasibility Studies,
pubmed-meshheading:19903661-Female,
pubmed-meshheading:19903661-Glomerular Filtration Rate,
pubmed-meshheading:19903661-Humans,
pubmed-meshheading:19903661-Kidney Diseases,
pubmed-meshheading:19903661-Male,
pubmed-meshheading:19903661-Middle Aged,
pubmed-meshheading:19903661-Renin-Angiotensin System,
pubmed-meshheading:19903661-Tetrazoles
|
pubmed:year |
2010
|
pubmed:articleTitle |
Feasibility of combined treatment with enalapril and candesartan in advanced chronic kidney disease.
|
pubmed:affiliation |
Department of Nephrology, Herlev Hospital, Denmark . marfri01@heh.regionh.dk
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|